Free tool
FAERS Monitor: Halog
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017556 or its brand name (Halog, Halcinonide). Reports on generic versions are filed under their own applications.
Reports
194
Serious
59
30% of reports
Hospitalization
31
Death reported
8
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective23
- psoriasis19
- rash16
- pain13
- pruritus13
- arthralgia12
- diarrhoea10
- headache10
- nausea10
- fatigue9
- off label use9
- condition aggravated7
- depression7
- weight decreased7
- dyspnoea6
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 7 |
| 2013 | 8 |
| 2014 | 6 |
| 2015 | 15 |
| 2016 | 18 |
| 2017 | 33 |
| 2018 | 17 |
| 2019 | 13 |
| 2020 | 15 |
| 2021 | 15 |
| 2022 | 15 |
| 2023 | 13 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 5 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,965 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| psoriasisSignal | 19 | 15.8 | 10.3 | 250 |
| rashSignal | 16 | 4.0 | 2.5 | 33 |
| pruritusSignal | 13 | 3.7 | 2.2 | 23 |
| depressionSignal | 7 | 3.3 | 1.6 | 9 |
| arthralgiaSignal | 12 | 3.1 | 1.8 | 16 |
| weight decreasedSignal | 7 | 2.7 | 1.3 | 6 |
| condition aggravatedSignal | 7 | 2.5 | 1.2 | 5 |
| painSignal | 13 | 2.3 | 1.4 | 8 |
| drug ineffective | 23 | 1.9 | 1.3 | 9 |
| headache | 10 | 1.7 | 0.9 | 2 |
| diarrhoea | 10 | 1.7 | 0.9 | 2 |
| nausea | 10 | 1.4 | 0.7 | 1 |
| fatigue | 9 | 1.3 | 0.7 | 0 |
| dyspnoea | 6 | 1.1 | 0.5 | 0 |
| off label use | 9 | 1.1 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.